The effect of bovine endosteum-derived particles on the proliferation of human mesenchymal stem cells

Biomaterials

Volumn 31, Issue 21, 2010, Pages 5689-5699

  Nigro, Julie ^a,b,c   White, Jacinta F ^a,b   Ramshaw, John A M ^a,b   Haylock, David N ^a,b,c,d   Nilsson, Susan K ^a,b,c,d   Werkmeister, Jerome A ^a,b  

^a CSIRO   (Australia)

^b University of Melbourne   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d Australian Stem Cell Centre   (Australia)

Author keywords

Bioreactor; Bone marrow; Cell adhesion; Cell proliferation; Glycosaminoglycan; Mesenchymal stem cell

Indexed keywords

BONE MARROW; BONE MARROW CELLS; GLYCOSAMINOGLYCAN; GLYCOSAMINOGLYCANS; MESENCHYMAL STEM CELL;

ADHESION; BIOLOGICAL MATERIALS; BIOREACTORS; BONE; CELL ADHESION; CELL CULTURE; CELL PROLIFERATION; GLUCOSE;

STEM CELLS;

BIOMATERIAL; CHONDROITIN SULFATE; FIBRONECTIN; FUCOSE; GLYCOSAMINOGLYCAN; GLYCOSYLATED PROTEIN; HEPARAN SULFATE; LAMININ; MANNOSE; N ACETYLGALACTOSAMINE; N ACETYLGLUCOSAMINE; PERLECAN; PROTEOGLYCAN;

ANIMAL TISSUE; ARTICLE; BIOREACTOR; BONE MARROW; CELL ADHESION; CELL EXPANSION; CELL GROWTH; CELL LINEAGE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; COW; CULTURE MEDIUM; DEMINERALIZATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LECTIN BINDING; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; SULFATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; CARBOHYDRATES; CATTLE; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHONDROITIN SULFATES; EXTRACELLULAR MATRIX; HUMANS; MESENCHYMAL STEM CELLS; MULTIPOTENT STEM CELLS; STEM CELL NICHE;

BOVINAE;

EID: 77953028501     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.03.054     Document Type: Article

References (50)

1. Global Stem Cell and Advanced Technologies Market, 2009. Report No.: MKMK2496496.
2. Lazarus H.M., Haynesworth S.E., Gerson S.L., Rosenthal N.S., Caplan A.I. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 1995, 16:557-564.
3. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
4. Koga H., Muneta T., Nagase T., Nimura A., Ju Y.J., Mochizuki T., et al. Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit. Cell Tissue Res 2008, 333:207-215.
5. Horwitz E.M., Prockop D.J., Gordon P.L., Koo W.W., Fitzpatrick L.A., Neel M.D., et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 2001, 97:1227-1231.
6. Ma J., Ge J., Zhang S., Sun A., Shen J., Chen L., et al. Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res Cardiol 2005, 100:217-223.
7. Dixon J.A., Gorman R.C., Stroud R.E., Bouges S., Hirotsugu H., Gorman J.H., et al. Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction. Circulation 2009, 120:S220-S229.
8. Hamamoto H., Gorman J.H., Ryan L.P., Hinmon R., Martens T.P., Schuster M.D., et al. Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage. Ann Thorac Surg 2009, 87:794-801.
9. United States National Institute of Health. ClinicalTrials.gov. Bethesda: Lister Hill National Centre for Biomedical Communications. Online 2009 December. Available from URL: http://www.clinicaltrials.gov/ct2/results%3Fterm%3Dmesenchymal%2Bstem%2Bcells&show_down%3DY%23down.
10. Kuroda R., Ishida K., Matsumoto T., Akisue T., Fujioka H., Mizuno K., et al. Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthr Cartil 2007, 15:226-231.
11. Wakitani S., Imoto K., Yamamoto T., Saito M., Murata N., Yoneda M. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthr Cartil 2002, 10:199-206.
12. Wakitani S., Mitsuoka T., Nakamura N., Toritsuka Y., Nakamura Y., Horibe S. Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Cell Transplant 2004, 13:595-600.
13. Lazarus H.M., Koc O.N., Devine S.M., Curtin P., Maziarz R.T., Holland H.K., et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005, 11:389-398.
14. Chu L., Robinson D.K. Industrial choices for protein production by large-scale cell culture. Curr Opin Biotechnol 2001, 12:180-187.
15. Philp D., Chen S.S., Fitzgerald W., Orenstein J., Margolis L., Kleinman H.K. Complex extracellular matrices promote tissue-specific stem cell differentiation. Stem Cells 2005, 23:288-296.
16. Wu Q.F., Wu C.T., Dong B., Wang L.S. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2003, 11:15-21.
17. Yang Y., Rossi F.M., Putnins E.E. Ex vivo expansion of rat bone marrow mesenchymal stromal cells on microcarrier beads in spin culture. Biomaterials 2007, 28:3110-3120.
18. Weber C., Pohl S., Portner R., Wallrapp C., Kassem M., Geigle P., et al. Expansion and harvesting of hMSC-TERT. Open Biomed Eng J 2007, 1:38-46.
19. Malda J., Frondoza C.G. Microcarriers in the engineering of cartilage and bone. Trends Biotechnol 2006, 24:299-304.
20. Doctor J., Petraglia C., Loveland A., Dietz M., Minich E., Leung J., et al. Evaluating microcarriers for delivering human adult mesenchymal stem cells in bone tissue engineering. Dev Biol 2002, 247:505.
21. Nilsson S.K., Debatis M.E., Dooner M.S., Madri J.A., Quesenberry P.J., Becker P.S. Immunofluorescence characterization of key extracellular matrix proteins in murine bone marrow in situ. J Histochem Cytochem 1998, 46:371-377.
22. Nilsson S.K., Johnston H.M., Whitty G.A., Williams B., Webb R.J., Denhardt D.T., et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 2005, 106:1232-1239.
23. Nilsson S.K., Johnston H.M., Coverdale J.A. Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 2001, 97:2293-2299.
24. Muguruma Y., Yahata T., Miyatake H., Sato T., Uno T., Itoh J., et al. Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment. Blood 2006, 107:1878-1887.
25. Bitter T., Muir H.M. A modified uronic acid carbazole reaction. Anal Biochem 1962, 4:330-334.
26. Gimble J.M. Marrow stromal adipocytes. Marrow stromal cell culture 1998, 67-87. Cambridge University Press, Cambridge. J.N. Beresford, M.E. Owen (Eds.).
27. Gronthos S., Graves S.E., Ohta S., Simmons P.J. The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood 1994, 84:4164-4173.
28. Tew S.R., Murdoch A.D., Rauchenberg R.P., Hardingham T.E. Cellular methods in cartilage research: primary human chondrocytes in culture and chondrogenesis in human bone marrow stem cells. Methods 2008, 45:2-9.
29. Johnstone B., Hering T.M., Caplan A.I., Goldberg V.M., Yoo J.U. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 1998, 238:265-272.
30. Mackay A.M., Beck S.C., Murphy J.M., Barry F.P., Chichester C.O., Pittenger M.F. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 1998, 4:415-428.
31. Yoo J.U., Barthel T.S., Nishimura K., Solchaga L., Caplan A.I., Goldberg V.M., et al. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 1998, 80:1745-1757.
32. Zhao F., Chella R., Ma T. Effects of shear stress on 3-D human mesenchymal stem cell construct development in a perfusion bioreactor system: experiments and hydrodynamic modeling. Biotechnol Bioeng 2007, 96:584-595.
33. Badylak S.F., Tullius R., Kokini K., Shelbourne K.D., Klootwyk T., Voytik S.L., et al. The use of xenogeneic small intestinal submucosa as a biomaterial for Achilles tendon repair in a dog model. J Biomed Mater Res 1995, 29:977-985.
34. Brown B., Lindberg K., Reing J., Stolz D.B., Badylak S.F. The basement membrane component of biologic scaffolds derived from extracellular matrix. Tissue Eng 2006, 12:519-526.
35. Hodde J.P., Badylak S.F., Brightman A.O., Voytik-Harbin S.L. Glycosaminoglycan content of small intestinal submucosa: a bioscaffold for tissue replacement. Tissue Eng 1996, 2:209-217.
36. Hodde J.P., Record R.D., Liang H.A., Badylak S.F. Vascular endothelial growth factor in porcine-derived extracellular matrix. Endothelium 2001, 8:11-24.
37. Voytik-Harbin S.L., Brightman A.O., Kraine M.R., Waisner B., Badylak S.F. Identification of extractable growth factors from small intestinal submucosa. J Cell Biochem 1997, 67:478-491.
38. Klein G., Conzelmann S., Beck S., Timpl R., Muller C.A. Perlecan in human bone marrow: a growth-factor-presenting, but anti-adhesive, extracellular matrix component for hematopoietic cells. Matrix Biol 1995, 14:457-465.
39. Hayashi K., Madri J.A., Yurchenco P.D. Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan. J Cell Biol 1992, 119:945-959.
40. Majumdar M.K., Keane-Moore M., Buyaner D., Hardy W.B., Moorman M.A., McIntosh K.R., et al. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 2003, 10:228-241.
41. Lu H., Guo L., Kawazoe N., Tateishi T., Chen G. Effects of poly(l-lysine), poly(acrylic acid) and poly(ethylene glycol) on the adhesion, proliferation and chondrogenic differentiation of human mesenchymal stem cells. J Biomater Sci Polym Ed 2009, 20:577-589.
42. Li F., Lu S., Vida L., Thomson J.A., Honig G.R. Bone morphogenetic protein 4 induces efficient hematopoietic differentiation of rhesus monkey embryonic stem cells in vitro. Blood 2001, 98:335-342.
43. Kawasaki H., Suemori H., Mizuseki K., Watanabe K., Urano F., Ichinose H., et al. Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity. Proc Natl Acad Sci U S A 2002, 99:1580-1585.
44. Haylock D.N., Williams B., Johnston H.M., Liu M.C., Rutherford K.E., Whitty G.A., et al. Hemopoietic stem cells with higher hemopoietic potential reside at the bone marrow endosteum. Stem Cells 2007, 25:1062-1069.
45. Badylak S., Freytes D., Badylak S.F., Freytes D.O. Preparing an extracellular matrix (ECM)-derived gel, comprises comminuting an ECM, solubilizing ECM that has not been dialyzed by digesting, raising the pH of the digesting solution, and coagulating the solution 2008, US Patent No. 260831.
46. Livesey S.A., McQuillan D.J., Beniker H.D., Boerboom L.E., Haggard W.O. Repairing a defective organ or tissue using a nonparticulate acellular matrix made from a different collagen-based tissue 2003, US Patent No. 143207.
47. Sampath T.K., Reddi A.H. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc Natl Acad Sci U S A 1981, 78:7599-7603.
48. Sampath T.K., Nathanson M.A., Reddi A.H. In vitro transformation of mesenchymal cells derived from embryonic muscle into cartilage in response to extracellular matrix components of bone. Proc Natl Acad Sci U S A 1984, 81:3419-3423.
49. Lum L.Y., Cher N.L., Williams C.G., Elisseeff J.H. An extracellular matrix extract for tissue-engineered cartilage. IEEE Eng Med Biol Mag 2003, 22:71-76.
50. Schop D., Janssen F.W., Borgart E., de Bruijn J.D., van Dijkhuizen-Radersma R. Expansion of mesenchymal stem cells using a microcarrier-based cultivation system: growth and metabolism. J Tissue Eng Regen Med 2008, 2:126-135.